An unidentified actinomycete, RTI 
mals receiving an intraperitoneal injection displayed an incoordination of the hind limbs and impaired reflexes before showing signs of respiratory distress. These findings indicated that antimycin Al possesses a neurotoxic property separate from its well-documented property as a respiratory poison.
Antimycin A is a crystalline antibiotic produced by several Streptomyces strains (16) . Antimycin A is actually a family of different active substances designated as antimycins Al, A2, A3, and A4 which can be separated by exhaustive countercurrent distribution (8) . The components differ chemically from each other only in the alkyl side chains and they appear to have approximately the same biological activities. The total complex shows antifungal activity (7), insecticidal and miticidal properties (6) , exceptional piscicidal properties (2) , and lethality to rodents (16) .The accepted explanation for these properties is that antimycin A acts as a respiratory poison (16) . Indeed, antimycin A has been a powerful tool in exploring the intricacies of electron transport (3) .
During the toxicological evaluation of some Streptomyces cultures, a strain was found from which antimycin Al could be isolated simply and directly in good yield. Observation of the effect of antimycin A1 on mice revealed a spate of symptoms expected of a respiratory poison. In addition, it appeared to produce some neurotoxic symptoms.
MATERIALS AND METHODS
The microorganism used in this work was isolated from soil and has been tentatively identified as a Streptomyces sp. (RTI-246). This organism was main-tained on agar slants of Benedicts medium. It was grown in 2,800-ml Fernbach flasks containing 500 ml of 6% High Protein Cereal For Baby (Gerber Products Co., Fremont, Mich.). The flasks were incubated for 3 days at 25 C on a rotary shaker (210 rev/min, 1-inch stroke). One flask served to inoculate 10 liters of the same medium in a stirred jar fermentor (Model FS-314, New Brunswick Scientific Co., New Brunswick, N.J.) which was incubated at 30 C for 48 hr with an airflow of 2 liters per min and agitated with a double impellor at 450 rev/min. During the course of the fermentation, 30 ml of UCon LB-625 (Union Carbide Chemicals Co., New York, N.Y.) was added to each stirred jar for foam control. The cells were separated from the medium by filtration with the aid of 1,000 cc of diatomaceous earth per fermentor jar. The filter paper (Whatman no. 1) was placed over a circle of cheesecloth for more rapid filtration.
Melting points were determined on a Kofler melting point apparatus. Ultraviolet (UV) absorption spectra were determined on a recording spectrophotometer (Model 14, Cary Instrument Co., Monrovia, Calif.). Infrared (IR) absorption spectra were recorded on a double beam spectrophotometer (Model 221, PerkinElmer Corp., Norwalk, Conn.). The nuclear magnetic resonance (NMR) spectra were determined on a recording spectrometer (Model A-60, Varian Associates, Palo Alto, Calif.) at 60 mc in deuteriochloroform with tetramethyl-silane as an internal standard. Chemical shifts are reported in a ppm. Thin-layer chromatography was done on microscope slides coated with Silica Gel HF by using a solvent system of hexane-chloroform-methanol (4:4:1, v/v). Gas chromatography was done on a 1.8-m (6 ft) column of 5% SE-30 on 60-80 mesh Chromosorb P with a thermal conductivity sensor (Model 700, F & M Scientific Corp., Avondale, Calif.).
ISOLATION AND TOXICOLOGY OF ANTIMYCIN Al
The pharmacological and toxicological properties of antimycin Al were determined in female Swiss albino mice strain DUB/ICR (Dublin Animal Laboratory, Dublin, Va). The compound was dissolved in sterol diluent (22) because of its low solubility and instability in most common solvents and vehicles (16) . The concentration of the stock solution was 1.0 mg/ml. This solution was found to be stable for at least 2 months at -70 C by lethality assays. The stock solution or dilutions made in the same diluent were injected at six dose levels into mice weighing 20 to 25 g. Ten mice per dose level were used. The animals were maintained for 72 hr and the deaths were recorded. The LD50 values were calculated by the method of Miller and Tainter (11) . A pharmacological evaluation of the compound was done by essentially the blind pharmacological screen of Turner (18) supplemented by some motor deficit tests. The intensity of the physiological signs was recorded on a 0 to + + + + basis.
RESULTS
Isolation. The moist filter cake containing cells obtained from 10 liters of submerged culture was homogenized in 4 liters of acetone in a blendor for 2 min at room temperature and filtered. This extraction was repeated twice and the filtrates were combined. The extract was concentrated under reduced pressure to remove the acetone and to give an aqueous solution containing suspended solids. This concentrate was extracted 3 times with 10 volumes of n-hexane. The hexane extract was concentrated under reduced pressure to give 14.1 g of a gray oil. This oil was dissolved in hot benzene and cooled to give 2.6 g of crystals. Addition of hexane yielded an additional 3.5 g of crystals. The IR spectra of these two samples were identical. The 2.6-g sample was recrystallized from a benzene and hexane mixture to give 2.3 g of crystals melting at 147 to 149 C. Recrystallizing twice more from the same solvent yielded 2 (12) reported that antimycin A, showed maximal UV (CH30H) absorbancy at 224 to 228 nm (e 36,600) and 320 to 323 nm (e 6,700). In addition, the IR and NMR spectral data were essentially identical to the data reported by Van Tamelen et al. (19) for antimycin Al. The mass spectral data was also suggestive of antimycin Al.
However, the complexity of this compound, the close similarity of antimycin Al to other antimycin A components, and the previously unreported direct isolation indicated additional proof was desirable. Previous chemical studies of antimycin A, showed that mild alkaline treatment results in cleavage to antimycic acid, formic acid, and a neutral, nitrogen-free lactone (9) . Since antimycin A, differs from the other antimycin components only in the nature of the alkyl side chain appearing in the lactone degradation product, the tentatively identified material was treated similarly and the lactone was separated and characterized.
A benzene solution of the compound (0.300 g in 20 ml) was extracted twice with 3 ml of 1 N sodium hydroxide and washed once with water. The benzene extracts were dried with anhydrous sodium sulfate and concentrated to 0.153 g of a liquid. The liquid was distilled in a microdistillation apparatus at a pot temperature of 111 C at 0.01 mm. A gas chromatogram of the distilled material showed one peak. This distillate had the following IR absorption (CH2CI2), 1,770 (lactone C=O), 1 Death in all cases was preceded by respiratory distress, mydriasis, cyanosis, vasoconstriction, salivation, and piloerection. Animals receiving an ip injection displayed an incoordination of the hind limbs and impaired pinnal, corneal, placing, positioning, and grasping reflexes before the animals exhibited respiratory distress. These neurotoxic signs either were not present or were reduced in degree in animals receiving an iv injection and they coincided with, rather than preceded, the respiratory distress.
DISCUSSION
Rieske (14) commented that toxicity studies in higher animals with antimycin have been somewhat fragmentary and plagued with discrepancies in the response of a given organism to different preparations of antimycin A. The iv LD50 value of antimycin A was reported by Strong (16) and Nakayama, Okamoto, and Harada (12) to be 0.9 mg/kg, which compares with the present value of 1.0 mg/kg for the Al subcomponent. On the other hand, they reported the ip LD5o of the combined components to be 7.6 mg/kg as compared to the present value of 1.50 0.19 mg/kg for the Al subcomponent. Blastmycin which Liu and Strong (8) found to be composed of antimycin A3 and A4 was reported by Watanabe et al. (21) to have an ip LD50 of 1.8 mg/kg. However, this comparison is suspect, since WE tanabe et al. (21) asserted their preparation of blastmycin differed from antimycin A in melting point, IR spectrum, antimicrobial spectrum, color reactions, and elemental analysis. Herr, Greselin, and Chappel (5) determined more recently the ip LD50 value in mice of the antimycin A complex to be 1.7 t 0.04 mg/kg, which agrees well with our value for the Al subcomponent. These combined results suggest that there are no significant differences in the toxicities of the subcomponents. However, this point should be determined experimentally since A3 has been reported to have at least five times the antimicrobial activity of A1 (8) and since Tappel (17) found A1 to be considerably more inhibitory than A2 or A3 toward succinatecytochrome c reductase. It is possible that many of the discrepancies in the toxicity studies on antimycin A are caused by the well-documented variation in composition of the complex (8, 14) . Certainly, it is elementary to pharmacology and toxicology that mixtures can have different properties than pure compounds.
The ability to distinguish among the subcomponents in their activities in intact biological systems suggests that the usefulness of antimycin A would be extended if the subcomponents were available in quantity for the role they best fulfilled. The present findings appear to be a stride in that direction. The yield of antimycin A1 is about 10 times greater than the early reported yields of the antimycin A complex (10, 12, 15) . A strain improvement program based on the orginal antimycin A-producing culture has resulted in approximately a 100-fold increase in yield of the antimycin A complex (20) . A similar program based on the current antimycin A1-producing culture might result in an even more superior strain. In addition, the simple isolation of antimycin A1 without recourse to exhaustive countercurrent distribution suggests the other subcomponents could be obtained similarly with the proper strain and conditions.
The occurrence of mydriasis, vasoconstriction, salivation, and piloerection among the signs associated with the respiratory distress preceding death from antimycin A1 suggest sympathomimetic activity. However, these signs have been seen as secondary effects of agents which produce histotoxic hypoxia (13) and thus do not contradict the well-established activity of antimycin A as a respiratory poison. The finding of dark red patches in the lungs on gross postmortem examination also confirms an earlier report by Ahmad, Schneider, and Strong (1) . Nevertheless, not all the observations reported here can be readily interpreted on the basis of antimycin Al being solely a respiratory poison. The disorganized coordination of the hind limbs and impaired reflexes found before the advent of respiratory distress in mice receiving ip injections indicates a separation of neurotoxic properties from respiration-inhibiting properties. This tends to confirm the observation of Giacobini (4) that the concentration of antimycin A required to inhibit respiration was approximately 10 times that required to inhibit the impulse activity of isolated neurons. The separation of effects after ip injection but not iv injection is probably the result of an iv dose being immediately available for activity.
